JP Morgan Chase’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-25,000
Closed -$5.09M – 7563
2024
Q2
$5.09M Buy
+25,000
New +$5.09M ﹤0.01% 3021
2024
Q1
– Sell
-3,000
Closed -$682K – 7673
2023
Q4
$682K Hold
3,000
– – ﹤0.01% 4583
2023
Q3
$603K Buy
3,000
+1,254
+72% +$264K ﹤0.01% 4374
2023
Q2
$362K Hold
1,746
– – ﹤0.01% 4688
2023
Q1
$344K Buy
+1,746
New +$359K ﹤0.01% 4725
2022
Q2
– Sell
-40,507
Closed -$9.18M – 6692
2022
Q1
$9.18M Buy
+40,507
New +$9.53M ﹤0.01% 2461
2020
Q3
– Sell
-42,952
Closed -$6.13M – 5634
2020
Q2
$6.13M Sell
42,952
-100,453
-70% -$13.9M ﹤0.01% 2309
2020
Q1
$15.6M Buy
+143,405
New +$20.7M ﹤0.01% 1421
2019
Q4
– Sell
-22,814
Closed -$3.29M – 5765
2019
Q3
$3.29M Buy
+22,814
New +$3.33M ﹤0.01% 3054

Other funds holding LH

JP Morgan Chase's LH Position: Q2 2026 in Review

JP Morgan Chase reduced its Labcorp (LH) stake by 17% in Q2 2026, selling an estimated $69.5M and leaving 1,268,384 shares worth $355M. The position accounts for 0.02% of the portfolio, ranked #559.

JP Morgan Chase first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $498M in Q4 2022. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • JP Morgan Chase held 1,268,384 shares of Labcorp worth $355M as of Q2 2026.
  • JP Morgan Chase sold 264,339 Labcorp shares in Q2 2026, an estimated $69.5M.
  • Labcorp made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #559 holding.
  • JP Morgan Chase first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Labcorp position peaked at $498M in Q4 2022.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.